
Neuland Laboratories Ltd is Rated Hold by MarketsMOJO
2026-11-15 10:10:05Neuland Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Nov 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreNeuland Laboratories’ Mixed Week: -0.02% Price Change Amid Technical Shifts and Financial Fluctuations
2026-11-08 13:00:08Key Events This Week Nov 2: Stock opens at Rs.19,576.05, down 0.63% despite Sensex rallying 1.57% Nov 3: Further decline to Rs.19,435.20 (-0.72%) as technical concerns emerge Nov 4: Mixed quarterly results announced; stock rebounds to Rs.19,614.30 (+0.92%) Nov 5: Technical momentum shifts to mildly bullish; price rises to Rs.19,771.85 (+0.80%) Nov 6: Slight pullback to Rs.19,696.75 (-0.38%) as week closes <div ...
Read More
Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-11-05 08:01:00Neuland Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Recent technical indicators, including MACD, RSI, and moving averages, suggest a cautiously optimistic outlook for this pharmaceuticals and biotechnology small-cap, supported by a Mojo Grade upgrade from Sell to Hold.
Read More
Neuland Laboratories Ltd Reports Mixed Quarterly Results Amid Positive Financial Trend
2026-11-04 11:00:13Neuland Laboratories Ltd has demonstrated a notable shift in its financial trajectory with a positive trend emerging in the latest half-year results, despite a challenging quarterly performance. The company’s recent figures reveal strong growth in profitability and operational efficiency over six months, contrasting with a decline in quarterly sales and earnings compared to the previous year’s averages.
Read More
Neuland Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-11-04 08:01:05Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market environment for the small-cap pharmaceutical player.
Read More
Neuland Laboratories Ltd is Rated Buy
2026-10-23 10:10:33Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Neuland Laboratories Ltd is Rated Buy by MarketsMOJO
2026-10-12 10:10:44Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read More
Neuland Laboratories Ltd is Rated Buy
2026-10-01 10:10:47Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-09-28 08:00:46Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a marginal day decline of 0.02%, the stock’s long-term performance remains robust, outpacing the Sensex significantly over multiple time horizons. This article analyses the latest technical indicators, price momentum, and what these signals imply for investors eyeing this stock.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSECopy of Newspaper Publication
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Nov-2026 | Source : BSEIntimation about Schedule of Analyst / Institutional Investor Meeting on November 17 2026
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06-Nov-2026 | Source : BSETranscript of the Earnings Call conducted on November 3 2026
Corporate Actions
No Upcoming Board Meetings
Neuland Laboratories Ltd has declared 340% dividend, ex-date: 24 Jul 26
No Splits history available
No Bonus history available
Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14